Close up Anticavity Toothpaste

Description

No specific description details are available for SPL code 34089-3.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider the overall clinical context when prescribing this medication.

Dosage and Administration

The product is intended for dental use and should be applied as directed for brushing. Each application contains Sodium Fluoride at a concentration of 0.27 g per 113.4 g of toothpaste. Healthcare professionals should instruct patients to use the product as part of their regular oral hygiene routine, ensuring that it is applied effectively during brushing to maximize fluoride delivery to the teeth.

Contraindications

Use is contraindicated in children under 6 years of age. Due to the risk of accidental ingestion, if more than the recommended amount is used for brushing and is accidentally swallowed, seek medical assistance or contact a poison control center immediately.

Warnings and Precautions

It is imperative to keep this product out of reach of children under 6 years of age to prevent accidental ingestion. In the event that more than the recommended amount is used for brushing and is accidentally swallowed, immediate medical assistance should be sought. Healthcare professionals are advised to contact a poison control center without delay to ensure appropriate management and care.

Side Effects

Patients should be aware of the following warnings associated with the use of this product. It is imperative to keep the product out of reach of children under 6 years of age to prevent accidental ingestion. In the event that more than the recommended amount is used for brushing and the product is accidentally swallowed, immediate medical assistance should be sought, or a poison control center should be contacted without delay.

These precautions are critical to ensure the safety and well-being of patients, particularly young children who may be more susceptible to adverse effects from improper use.

Drug Interactions

There are no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions between this drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Close up Anticavity Toothpaste (anticavity toothpaste). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 6 years of age should not have access to this product, as it is intended for older children and adults. In the event that more than the recommended amount is used for brushing and is accidentally swallowed, immediate medical assistance should be sought, or a poison control center should be contacted.

Geriatric Use

There is no specific information regarding the use of Close Up Anticavity Toothpaste in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise clinical judgment when recommending this product to elderly patients, as individual health status and oral care needs may vary. Monitoring for any adverse effects or changes in oral health is advisable when this product is used in the geriatric population.

Pregnancy

There is no specific information regarding the use of Close Up Anticavity Toothpaste during pregnancy. As such, healthcare professionals should exercise caution when recommending this product to pregnant patients. The absence of data does not preclude the possibility of unknown risks; therefore, it is advisable to consider the potential benefits and risks on a case-by-case basis. Women of childbearing potential should be informed of the lack of available information and encouraged to consult their healthcare provider for personalized advice.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the effects on breastfed infants are not established. It is advisable to weigh the potential benefits against any unknown risks when considering treatment options for lactating patients.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient factors when prescribing to patients with renal impairment, as the absence of detailed guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, particularly if an amount exceeding that recommended for brushing is accidentally ingested, it is imperative to seek immediate medical assistance. Healthcare professionals should advise patients or caregivers to contact a poison control center without delay.

Prompt intervention is crucial in managing potential complications arising from overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and address any adverse effects that may arise from the ingestion.

Management procedures should include a thorough evaluation of the patient's condition, monitoring for any signs of toxicity, and implementing appropriate treatment protocols as necessary. It is essential to follow established guidelines for the management of overdoses to ensure patient safety and effective care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children under 6 years of age to prevent accidental ingestion.

In the event that the product is accidentally swallowed, healthcare providers should instruct patients to seek medical help or contact a poison control center immediately.

Additionally, healthcare providers may inform patients that they can reach out with any questions or comments by calling 1-800-786-5135, available Monday through Friday from 9 AM to 5 PM ET.

Storage and Handling

The product is supplied in configurations that ensure safety and efficacy. It is essential to keep this product out of reach of children under 6 years of age to prevent accidental ingestion or misuse.

For optimal storage, the product should be maintained at controlled room temperature, away from direct sunlight and moisture. Specific container requirements must be adhered to, ensuring that the product remains sealed and protected from environmental factors that could compromise its integrity. Special handling precautions should be observed to maintain the product's quality and effectiveness throughout its shelf life.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Close up Anticavity Toothpaste, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)